BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1655172)

  • 1. Phosphoinositide hydrolysis linked 5-HT2 receptors in fibroblasts from choroid plexus.
    Barker EL; Burris KD; Sanders-Bush E
    Brain Res; 1991 Jun; 552(2):330-2. PubMed ID: 1655172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium.
    Esterle TM; Sanders-Bush E
    J Neurosci; 1992 Dec; 12(12):4775-82. PubMed ID: 1334504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT-induced transferrin production by choroid plexus epithelial cells in culture: role of 5-HT1c receptor.
    Tsutsumi M; Sanders-Bush E
    J Pharmacol Exp Ther; 1990 Jul; 254(1):253-7. PubMed ID: 2164094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic agonists stimulate inositol lipid metabolism in rabbit platelets.
    Schächter M; Godfrey PP; Minchin MC; McClue SJ; Young MM
    Life Sci; 1985 Oct; 37(17):1641-7. PubMed ID: 2997568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
    Ferry RC; Unsworth CD; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.
    Conn PJ; Sanders-Bush E; Hoffman BJ; Hartig PR
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4086-8. PubMed ID: 2940597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced phosphoinositide hydrolysis in choroid plexus.
    Conn PJ; Sanders-Bush E
    J Neurochem; 1986 Dec; 47(6):1754-60. PubMed ID: 3021903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Helsley S; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
    Pierce PA; Peroutka SJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.
    Claustre Y; Eudeline B; Benavides J; Scatton B
    Eur J Pharmacol; 1992 Jan; 225(1):37-41. PubMed ID: 1311687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of phosphoinositide hydrolysis by serotonin in C6 glioma cells.
    Ananth US; Leli U; Hauser G
    J Neurochem; 1987 Jan; 48(1):253-61. PubMed ID: 3025366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Life Sci; 1990; 47(22):2009-19. PubMed ID: 2273941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus.
    Kaufman MJ; Hartig PR; Hoffman BJ
    J Neurochem; 1995 Jan; 64(1):199-205. PubMed ID: 7798914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
    Barker EL; Sanders-Bush E
    Mol Pharmacol; 1993 Oct; 44(4):725-30. PubMed ID: 8232222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
    Burris KD; Breeding M; Sanders-Bush E
    J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.
    Conn PJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1987 Aug; 242(2):552-7. PubMed ID: 3039120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
    J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denervation supersensitivity of 5-HT-1c receptors in rat choroid plexus.
    Conn PJ; Janowsky A; Sanders-Bush E
    Brain Res; 1987 Jan; 400(2):396-8. PubMed ID: 3815085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.